GPR40 signaling affects fatty acid β-oxidation in β-cells. (a) Ketone body β- hydroxybutyrate (BHB) production in INS1E β-cells in the presence of C8, C10 or C8:C10 40:60 mixture. (b) Inhibition of GPR40 signaling by the antagonist, GW1100 (GW), (c) the phospholipase C-β (PLCβ) inhibitor, U73122 (U7) and nifedipine (Nif) prevent BHB production from medium chain fatty acids (MCFA) in INS1E β-cells unlike the IP3 receptor inhibitor xantospongin (Xant). (d) Inhibition of GPR40 signaling by GW increased complete β-oxidation of palmitate. Data are presented as means + SEM of three independent experiments, * p < 0.05, ** p < 0.01 relative to control.